Companies / ADC Therapeutics SA
ADC Therapeutics SA
NYSE: ADCTForeign · IFRSCIK 1771910EPALINGES
Financials · FY2025
Ownership
127.2M shares outstanding · as of Apr 27, 2026
Ownership
| Insiders | 2.90% | 3,684,726 |
| Public float | 97.10% | 123,506,432 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Mallik AmeetCEOChief Executive Officer · Director | 1.14% | 1,446,769 |
Carmona JoseChief Financial Officer | 0.58% | 734,376 |
Zaki MohamedChief Medical Officer | 0.54% | 682,417 |
Graham Peter JChief Legal Officer | 0.49% | 620,540 |
Kallebo Lisa MichelleChief Accounting Officer | 0.10% | 128,224 |
Coughlin TimothyDirector | 0.06% | 72,400 |
Institutional holders 0
| Holder | Value | % of shares |
|---|---|---|
| No institutional holders on file. | ||
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Mallik Ameet CEO | Grant | Common Shares | $3.59M | +900K +138.46% | 1,550,000 1.22% of shares | low |
| Feb 13, 2026 | Graham Peter J Executive | Grant | Common Shares | $1.18M | +295K +82.11% | 653,834 0.51% of shares | low |
| Feb 13, 2026 | Zaki Mohamed Executive | Grant | Common Shares | $1.14M | +285K +67.61% | 707,020 0.56% of shares | low |
| Feb 13, 2026 | Carmona Jose Executive | Grant | Common Shares | $1.08M | +272K +55.58% | 760,256 0.60% of shares | low |
| Feb 13, 2026 | Mallik Ameet CEO | Other | Common Shares | $411.9K | -103K -6.66% | 1,446,769 1.14% of shares | low |
| Feb 13, 2026 | Kallebo Lisa Michelle Executive | Grant | Common Shares | $251.0K | +63K +88.90% | 133,657 0.11% of shares | low |
| Feb 13, 2026 | Graham Peter J Executive | Other | Common Shares | $132.8K | -33K -5.09% | 620,540 0.49% of shares | low |
| Feb 13, 2026 | Carmona Jose Executive | Other | Common Shares | $103.3K | -26K -3.40% | 734,376 0.58% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Orbimed Advisors LLC | Passive13G/A | — |
| Redmile Group, LLC | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G/A | — |
| Prosight Management, LP | Passive13G/A | — |
| TCG Crossover GP II, LLC | Passive13G | — |